Retirement Systems Of Alabama Intercept Pharmaceuticals, Inc. Transaction History

Retirement Systems Of Alabama

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Jul 17, 2018	SELL	$60.0 - $85.67 $2.09 Million - $2.99 Million	-34,900 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$58.2 - $72.76 $2.03 Million - $2.54 Million	34,900	34,900 $2.04 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

Stay updated on Retirement Systems Of Alabama with notifications on news.